Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 8, 2008 (February 7, 2008)

Commission File Number: 0-24260

 

 

Amedisys, Inc.

(Exact Name of Registrant as specified in Charter)

 

 

 

Delaware   11-3131700

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

(225) 292-2031 or (800) 467-2662

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Information to be included in the report


Section 7 — Regulation FD

Item 7.01. Regulation FD Disclosure.

On February 8, 2008, Amedisys, Inc. (the “Company”) issued a press release announcing that it had signed a definitive agreement to acquire home health agencies in the CON states of Kentucky and Tennessee. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of this Current Report on Form 8-K, the information presented herein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Exchange Act of 1933, as amended, except as previously set forth by specific reference in such a filing.

Section 9 — Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits

(a) Financial Statements of Business Acquired.

Not applicable

(b) Pro Forma Financial Information.

Not applicable

(c) Shell Company Transactions.

Not applicable

(d) Exhibits

 

99.1    Press release dated February 8, 2008, announcing the Company’s execution of a definitive agreement to acquire home health agencies in the CON states of Kentucky and Tennessee.

 

2


Signature(s)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      Amedisys, Inc.
Date: February 8, 2008     By:  

/s/ Dale E. Redman

        Dale E. Redman
        Chief Financial Officer

 

3


Exhibit Index

 

Exhibit No.

  

Description

EX-99.1    Press release dated February 8, 2008, announcing the Company’s execution of a definitive agreement to acquire home health agencies in the CON states of Kentucky and Tennessee.

 

4